amgen glp 1 drug could threaten Novo Nordisk, Eli Lilly weight loss dominance Comparing Ozempic, Wegovy and Other
Description
When Wegovy, the brand semaglutide marketed for weight management, began experiencing shortages, some using the medicine were prescribed off-brand Ozempic, makin the drug much harder to find
This body of data suggests that there may be synergistic activity between GLP1 agonist and other metabolic pathway therapies
Making drugs that stick around Despite all their activity in the body and brain, naturally occurring GLP-1 hormones dont make good drugs
J Nutr Sci Vitaminol
[DOI] [PubMed] [Google Scholar] 111.Liu H, Zhang S, Zhou Z, Xing M, Gao Y
Maybe so
